A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cells

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Li, Ying ^a,b   Balasubramanian, Umamahesw ^a,b   Cohen, Devon ^a,b   Zhang, Ping Wu ^a,b   Mosmiller, Elizabeth ^a,b   Sattler, Rita ^a,b   Maragakis, Nicholas J ^a,b   Rothstein, Jeffrey D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; COPPER ZINC SUPEROXIDE DISMUTASE; FUSED IN SARCOMA PROTEIN; VALOSIN CONTAINING PROTEIN; C9ORF72 PROTEIN, HUMAN; PROTEIN; SUPEROXIDE DISMUTASE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANG GENE; ARTICLE; C9ORF72 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS; FAMILIAL DISEASE; FEMALE; FIG4 GENE; FUS GENE; GENE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROGLIA; MALE; MIDDLE AGED; MOLECULAR LIBRARY; NERVE CELL DIFFERENTIATION; PLURIPOTENT STEM CELL; SOD1 GENE; VCP GENE; ASTROCYTE; CELL CULTURE; CELL DIFFERENTIATION; GENETICS; HEALTH CARE FACILITY; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY;

RODENTIA;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MIDDLE AGED; MUTATION; PROTEINS; SUPEROXIDE DISMUTASE; TISSUE BANKS;

EID: 84924428880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118266     Document Type: Article

References (64)

1. Mulder DW (1982) Clinical limits of amyotrophic lateral sclerosis. Adv Neurol 36: 15-22. PMID: 7180681
2. Rothstein JD (2009) Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65 Suppl 1: S3-9. doi: 10.1002/ana.21543 PMID: 19191304
3. Pasinelli P, Brown RH (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7: 710-723. PMID: 16924260
4. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72: 245-256. doi: 10.1016/j.neuron.2011.09.011 PMID: 21944778
5. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257-268. doi: 10.1016/j.neuron.2011.09.010 PMID: 21944779
6. Da Cruz S, Cleveland DW (2011) Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol 21: 904-919. doi: 10.1016/j.conb.2011.05.029 PMID: 21813273
7. Majounie E, Renton AE, Mok K, Dopper EG, Waite A, et al. (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11: 323-330. doi: 10.1016/S1474-4422(12)70043-1 PMID: 22406228
8. Johnson JO, Pioro EP, Boehringer A, Chia R, Feit H, et al. (2014) Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci 17: 664-666. doi: 10.1038/nn.3688 PMID: 24686783
9. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772-1775. PMID: 8209258
10. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, et al. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116. PMID: 7605627
11. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62. PMID: 8446170
12. Deng HX, Shi Y, Furukawa Y, Zhai H, Fu R, et al. (2006) Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc Natl Acad Sci U S A 103: 7142-7147. PMID: 16636275
13. Cheah BC, Vucic S, Krishnan AV, Kiernan MC (2010) Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 17: 1942-1199. PMID: 20377511
14. Benatar M (2007) Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis 26: 1-13. PMID: 17300945
15. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872. PMID: 18035408
16. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920. PMID: 18029452
17. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, et al. (2008) Disease-specific induced pluripotent stem cells. Cell 134: 877-886. doi: 10.1016/j.cell.2008.07.041 PMID: 18691744
18. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, et al. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218-1221. doi: 10.1126/science.1158799 PMID: 18669821
19. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, et al. (2009) Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136: 964-977. doi: 10.1016/j. cell.2009.02.013 PMID: 19269371
20. Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, et al. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457: 277-280. doi: 10.1038/nature07677 PMID: 19098894
21. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, et al. (2009) Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461: 402-406. doi: 10. 1038/nature08320 PMID: 19693009
22. Hotta A, Cheung AY, Farra N, Vijayaragavan K, Seguin CA, et al. (2009) Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 6: 370-376. doi: 10.1038/nmeth. 1325 PMID: 19404254
23. Di Domenico AI, Christodoulou I, Pells SC, McWhir J, Thomson AJ (2008) Sequential genetic modification of the hprt locus in human ESCs combining gene targeting and recombinase-mediated cassette exchange. Cloning Stem Cells 10: 217-230. doi: 10.1089/clo.2008.0016 PMID: 18386992
24. Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, et al. (2012) Drug Screening for ALS Using Pa-tient-Specific Induced Pluripotent Stem Cells. Sci Transl Med 4: 145ra104. doi: 10.1126/scitranslmed. 3004052 PMID: 22855461
25. Chen H, Qian K, Du Z, Cao J, Petersen A, et al. (2014) Modeling ALS with iPSCs Reveals that Mutant SOD1 Misregulates Neurofilament Balance in Motor Neurons. Cell Stem Cell 14: 796-809. doi: 10. 1016/j.stem.2014.02.004 PMID: 24704493
26. Kiskinis E, Sandoe J, Williams LA, Boulting GL, Moccia R, et al. (2014) Pathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant SOD1. Cell Stem Cell 14: 781-795. doi: 10.1016/j.stem.2014.03.004 PMID: 24704492
27. Re DB, Le Verche V, Yu C, Amoroso MW, Politi KA, et al. (2014) Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 81: 1001-1008. doi: 10.1016/j.neuron. 2014.01.011 PMID: 24508385
28. Boillee S, Vande Velde C, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59. PMID: 17015226
29. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, et al. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392. PMID: 16741123
30. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, et al. (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11: 251-253. doi: 10.1038/nn2047 PMID: 18246065
31. Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, et al. (2013) Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci 16: 571-579. doi: 10.1038/nn.3357 PMID: 23542689
32. Papadeas ST, Kraig SE, O'Banion C, Lepore AC, Maragakis NJ (2011) Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Proc Natl Acad Sci U S A 108: 17803-17808. doi: 10.1073/pnas.1103141108 PMID: 21969586
33. Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC (2008) Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3: 637-648. doi: 10.1016/j.stem.2008.09.017 PMID: 19041780
34. Marchetto MC, Muotri AR, Mu Y, Smith AM, Cezar GG, et al. (2008) Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3: 649-657. doi: 10.1016/j.stem.2008.10.001 PMID: 19041781
35. Donnelly CJ, Zhang PW, Pham JT, Heusler AR, Mistry NA, et al. (2013) RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80: 415-428. doi: 10.1016/j. neuron.2013.10.015 PMID: 24139042
36. Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, et al. (2014) Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS. Neuron.
37. Wray S, Self M, Lewis PA, Taanman JW, Ryan NS, et al. (2012) Creation of an open-access, mutationdefined fibroblast resource for neurological disease research. PLoS One 7: e43099. doi: 10.1371/ journal.pone.0043099 PMID: 22952635
38. Hu BY, Zhang SC (2009) Differentiation of spinal motor neurons from pluripotent human stem cells. Nat Protoc 4: 1295-1304. doi: 10.1038/nprot.2009.127 PMID: 19696748
39. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, et al. (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27: 275-280. doi: 10.1038/nbt.1529 PMID: 19252484
40. Roybon L, Lamas NJ, Garcia-Diaz A, Yang EJ, Sattler R, et al. (2013) Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. Cell Rep 4: 1035-1048. doi: 10.1016/j. celrep.2013.06.021 PMID: 23994478
41. Liu Y, Han SS, Wu Y, Tuohy TM, Xue H, et al. (2004) CD44 expression identifies astrocyte-restricted precursor cells. Dev Biol 276: 31-46. PMID: 15531362
42. Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Mistry NA, et al. (2013) RNA toxicity from the ALS/ FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80: 415-428. doi: 10.1016/j. neuron.2013.10.015 PMID: 24139042
43. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, et al. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26: 1276-1284. doi: 10.1038/ nbt.1503 PMID: 18931654
44. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, et al. (2009) Generation of induced pluripotent stem cells from human blood. Blood 113: 5476-5479. doi: 10.1182/blood-2009-02-204800 PMID: 19299331
45. Robinton DA, Daley GQ (2012) The promise of induced pluripotent stem cells in research and therapy. Nature 481: 295-305. doi: 10.1038/nature10761 PMID: 22258608
46. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676. PMID: 16904174
47. Zhou W, Freed CR (2009) Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27: 2667-2674. doi: 10.1002/stem.201 PMID: 19697349
48. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85: 348-362. PMID: 19838014
49. Woltjen K,Michael IP,Mohseni P, Desai R, Mileikovsky M, et al. (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458: 766-770. doi: 10.1038/nature07863 PMID: 19252478
50. Kaji K, Norrby K, Paca A, MileikovskyM,Mohseni P, et al. (2009) Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458: 771-775. doi: 10.1038/nature07864 PMID: 19252477
51. Jia F, Wilson KD, Sun N, Gupta DM, Huang M, et al. (2010) A nonviral minicircle vector for deriving human iPS cells. Nat Methods 7: 197-199. doi: 10.1038/nmeth.1426 PMID: 20139967
52. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, et al. (2009) Human induced pluripotent stemcells free of vector and transgene sequences. Science 324: 797-801. doi: 10.1126/science.1172482 PMID: 19325077
53. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, et al. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7: 618-630. doi: 10.1016/j.stem.2010.08.012 PMID: 20888316
54. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, et al. (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4: 472-476. doi: 10.1016/j. stem.2009.05.005 PMID: 19481515
55. Newman AM, Cooper JB (2010) Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7: 258-262. doi: 10.1016/j.stem.2010.06.016 PMID: 20682451
56. Yang Y, Gozen O, Watkins A, Lorenzini I, Lepore A, et al. (2009) Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1. Neuron 61: 880-894. doi: 10.1016/j.neuron.2009.02.010 PMID: 19323997
57. Kola I, Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3: 711-715. PMID: 15286737
58. Yang YM, Gupta SK, Kim KJ, Powers BE, Cerqueira A, et al. (2013) A Small Molecule Screen in Stem-Cell-Derived Motor Neurons Identifies a Kinase Inhibitor as a Candidate Therapeutic for ALS. Cell Stem Cell 12: 713-726. doi: 10.1016/j.stem.2013.04.003 PMID: 23602540
59. Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2: 806-819. PMID: 11715057
60. Yamanaka S (2012) Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10: 678-684. doi: 10.1016/j.stem.2012.05.005 PMID: 22704507
61. Grskovic M, Javaherian A, Strulovici B, Daley GQ (2011) Induced pluripotent stem cells-opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 10: 915-929. doi: 10.1038/nrd3577 PMID: 22076509
62. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38: 73-84. PMID: 7611729
63. Corti S, Nizzardo M, Nardini M, Donadoni C, Salani S, et al. (2010) Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis. Hum Mol Genet 19: 3782-3796. doi: 10.1093/hmg/ddq293 PMID: 20650960
64. Ganel R, Ho T, Maragakis NJ, Jackson M, Steiner JP, et al. (2006) Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection. Neurobiol Dis 21: 556-567. PMID: 16274998